KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis

To our knowledge, this is the first report on the clinical impact of the fraction of KIT D816V mutation positive cells in ISM, which in the present study does not seem to correlate with clinical manifestations of the disease.